Kun Shi Van Wielink, PhD
About Kun Shi Van Wielink, PhD
Kun Shi Van Wielink, PhD, is the Associate Director of HEOR&RWE, Medical Affairs, Europe at BeiGene, based in Amsterdam, North Holland, Netherlands.
Current Role and Responsibilities
Kun Shi Van Wielink, PhD, currently serves as the Associate Director HEOR&RWE, Medical Affairs, Europe at BeiGene. Based in Amsterdam, North Holland, Netherlands, he focuses on health economics and outcomes research (HEOR) and real-world evidence (RWE). In this role, he leverages his extensive experience in medical affairs to drive strategic initiatives and provide scientific support for the European market.
Professional Experience in Oncology
Dr. Van Wielink has significant experience in oncology, having worked in various roles within the field. He was a Regional Medical Science Liaison Manager at Idera Pharmaceuticals and an Oncology Scientist at AMC - Academic Medical Center. His specialization includes cancer drug development and clinical trial design, with a focus on hemato-oncology and cancer therapeutics. His contributions have been pivotal in advancing oncology research and clinical practices.
Previous Roles at BeiGene
Before his current position at BeiGene, Kun Shi Van Wielink held multiple roles within the company. These include Senior Scientific Advisor, Medical Affairs - Netherlands & Nordics, Medical Science Liaison Manager - Netherlands & Nordics, and Medical Science Liaison Manager - Benelux. His responsibilities ranged from providing scientific advisory to managing medical liaison activities across different regions in Europe. These roles have enriched his expertise in medical affairs and stakeholder engagement.
Educational Background and Research
Kun Shi Van Wielink completed his PhD in Medical Oncology at AMC - Academic Medical Center and holds an MSc and BSc from Wageningen University & Research. During his academic journey, he undertook significant research projects, including an MSc internship in the Oncogenetics department at AMC and a major internship in the Experimental Therapy department at The Netherlands Cancer Institute. His Bachelor Thesis was conducted in the Organic Chemistry department at Wageningen UR, demonstrating his strong foundation in scientific research.
Consulting and Project Management Experience
Dr. Van Wielink has also contributed as a Consultant Clinical Development at SMS-oncology and served as an interim Project Manager at Siemens Health Care. In these capacities, he managed clinical development projects and healthcare sector initiatives, showcasing his versatility and project management skills. His role at SMS-oncology involved overseeing clinical trials and development strategies, further solidifying his expertise in clinical development and project execution.